Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.
about
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisInteraction between circulating cancer cells and platelets: clinical implicationGene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesisNitric oxide synthase modulates angiogenesis in response to tissue ischemiaCav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration.Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactinP-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancerModeration of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesisEpidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiologyRegulation of microvascular permeability by vascular endothelial growth factors.Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor.Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertensionConnexin43 phosphorylation by PKC and MAPK signals VEGF-mediated gap junction internalization.Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vesselsRevealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability.RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cellsRole of VEGF and CD44v6 in differentiating benign from malignant ascites.Characterization of the increase in vascular permeability induced by vascular permeability factor in vivoVascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.Ascorbic acid prevents VEGF-induced increases in endothelial barrier permeability.Endothelial Ca 2+ oscillations reflect VEGFR signaling-regulated angiogenic capacity in vivo.Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells.Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.Clinical neurosciences in the decade of the brain: hypotheses in neuro-oncology. VEG/PF acts upon the actin cytoskeleton and is inhibited by dexamethasone: relevance to tumor angiogenesis and vasogenic edema.The role of vascular endothelial growth factor in wound healing.Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology.Platelets and cancer angiogenesis nexus.Modulation of VEGF receptor 2 signaling by protein phosphatases.Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression.VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6.Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen.Vascular endothelial growth factor: environmental controls and effects in angiogenesis.Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
P2860
Q24684263-34188007-5E00-4900-9E54-EAB86E714196Q26778920-631410DB-ED5C-4C5C-B66A-3B40B561D331Q27320730-3FA5811D-2020-42C7-8BD5-CAE0FFB151F4Q28508302-7C7041EB-880A-45B5-A996-4C9BC58723B7Q28575971-83048D7A-7429-4426-B139-F66790AB5722Q33841033-11A3CA15-AF34-4A20-8D3E-7628A31AD615Q34121190-DF9B2F2B-3E47-404D-9910-F863E72190A4Q34171030-49923267-52D8-4E1B-ADC7-575C9044F453Q34238103-FB45C33E-1952-4DB4-9358-67558B7E431CQ34435505-8D35DB27-71DC-47DA-B258-7AADF427D8D2Q34774011-95927355-8E2E-4481-9A80-24D19AD02AB6Q35590232-A29A546C-5B18-4871-BF9C-1ED2B84E3A12Q35773499-4B6644FA-DC61-4A24-AE60-853D4BD5DFABQ35795581-E59C821F-FDFC-4C5F-BB99-174FC71D5E06Q35833414-9A1FFC3C-19C6-4386-B823-4AF054F843A1Q36063755-4CE5B1C5-D2AB-4FC7-9A78-64DFC4260065Q36230478-B7742E3B-6763-4C95-A727-D451990DA7F2Q36249423-D9E39AAA-328B-4CD5-9D69-AFB5ABE6887EQ36285714-2E311ABF-D6DA-4FC7-BC66-0A59FFDB7797Q36308920-B688AC73-A049-477C-BA3A-D8A78A451E50Q36329395-84C27F76-EDE9-4CB9-A4B7-A64604A5F81EQ36363302-F5A11A1F-9327-44CF-8DB1-0F08C73407C4Q36479728-56768AE1-A6FF-4BB4-9A02-3AFAB21EC956Q36483799-7FDA0B58-C1C4-478B-B744-8062495F640BQ36531886-0AB1D798-7930-48E3-9AD3-85DBD46A9D37Q36643769-C261F3CD-D1AC-4728-A5D6-000DD82B3848Q36987703-EAE9BEBE-2307-4C10-94E1-18AE485C1D31Q37308157-71AF018D-7B5E-40FF-A65B-4BC99B3690D3Q37366616-6D5965AE-AE3A-4B9C-B5A0-BA9971C7394FQ37368066-F286468E-9C1C-40F6-A6C4-A53D91AA2FA8Q37370535-4377013A-6126-4E91-812B-EFDBB9B40157Q37376612-E16140CC-087C-4321-ACB5-BE72D448A806Q38128286-419755AC-1038-4064-B628-13E0F439B115Q38691783-450BBAB2-3C29-47F0-827F-39542ED34257Q39020269-F71C97BD-D629-49E3-8B2F-22C30CCA6169Q39444857-6A00D763-5DE3-4D6D-980F-6AFB0340FB4FQ39938587-97E2878E-11F8-4194-B6AD-D05CCDBAD8C3Q39990465-29C89628-5690-4489-87E2-0284B40FD75DQ41078547-FBA240DB-2967-48E3-BE0D-914BA3BDBB81Q41866566-7223A7F6-7C52-4EA3-984B-8D1DDB6C034A
P2860
Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Tumor-secreted vascular permea ...... se in human endothelial cells.
@ast
Tumor-secreted vascular permea ...... se in human endothelial cells.
@en
type
label
Tumor-secreted vascular permea ...... se in human endothelial cells.
@ast
Tumor-secreted vascular permea ...... se in human endothelial cells.
@en
prefLabel
Tumor-secreted vascular permea ...... se in human endothelial cells.
@ast
Tumor-secreted vascular permea ...... se in human endothelial cells.
@en
P2093
P2860
P1476
Tumor-secreted vascular permea ...... se in human endothelial cells.
@en
P2093
P2860
P304
P407
P577
1991-01-01T00:00:00Z